病例报告:严重的高甘油三血和多血管冠状动脉疾病 - 管理和斑块特征
Baiba Kokina1,2, Maris Lapsovs2,3, Rudolfs Roze2,3
1Department of Residency, Riga Stradins University, Riga, Latvia.
Frontiers in cardiovascular medicine
|December 24, 2025
概括
严重的高甘油三血症可以在没有富含脂质的斑块的情况下发生. 这种病例突出了一个患有家族性过高甘油三血症和低斑块脂质含量的患者,通过胰岛素,肝素和血酶有效管理.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生化学
- 遗传学 是一个遗传学.
背景情况:
- 高甘油是心血管风险标志物.
- 文献表明,高甘油三和富含脂质的斑块之间存在联系.
- 这种病例呈现出严重的高甘油三血症,而没有富含脂质的动脉样硬化病变.
研究的目的:
- 报告严重的高甘油三血症病例与不寻常的呈现.
- 通过近红外光谱学 (NIRS) 调查严重高甘油三血症的斑块特征.
- 描述严重高甘油三血症的治疗方法.
主要方法:
- 冠状动脉扫描以评估冠状动脉疾病.
- 近红外光谱 (NIRS) 用于评估斑块脂质含量.
- 静脉注射胰岛素和肝素治疗,然后进行血酶以降低甘油三.
- 针对家族性高甘油三糖血症的遗传检测.
主要成果:
- 一名54岁的男性呈现了高于113.00 mmol/L的甘油三水平和严重的多血管疾病.
- 尼尔斯显示了低斑块脂质含量,在右冠状动脉的脂质核心负荷指数为0,尽管有>90%的狭窄.
- 在排放之前,甘油三水平迅速降至5.79 mmol/L.
- 基因检测证实了由于脂蛋白脂酶基因变异的家族性过高甘油血症.
结论:
- 严重升高的甘油三和早发性冠状动脉疾病可以与低斑块脂质含量并存.
- 尼尔斯是一个有价值的工具,用于评估斑块组成在高甘油三血症.
- 静脉注射胰岛素和肝素治疗可以有效地快速降低严重高甘油三血症的甘油三水平.
相关概念视频
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

